Drug Industry – Page 20

AstraZeneca CEO Pascal Soriot’s Pay Rise Signals Succession Planning

1 year ago talkbio0Tagged AstraZeneca, CEO, Drug Industry, executive compensation, Pascal Soriot, Succession planning

AstraZeneca, Pascal Soriot, CEO, pay rise, succession planning, pharmaceutical industry, executive compensation.

Strategic Acquisition, Partnership, and Development of Innovative Assets in Biopharma

1 year ago talkbio0Tagged Acquisition (action), Biopharma, development aspects, Drug Development, Drug Industry, innovative assets, Market, Partnership, Portfolio diversification, Risk Management, strategic decision-making, trends qualifier

Biopharma, Innovative Assets, Acquisition, Partnership, Development, Strategic Decision-Making, Pharmaceutical Industry, Drug Development, Market Trends, Risk Management, Portfolio Diversification

Day One Outshines Novartis: FDA Approves Ojemda for Wider Pediatric Brain Tumor Treatment

1 year ago talkbio0Tagged Brain Neoplasms, Cancer Therapeutic Procedure, Clinical Trials, Drug Industry, Novartis, Ojemda, Pediatric brand name, United States Food and Drug Administration

Day One, Novartis, FDA, Ojemda, pediatric brain tumor, cancer treatment, clinical trials, pharmaceutical industry.

Novartis Boosts 2024 Sales Forecast, Gears Up for Major Cancer Drug Expansions

1 year ago talkbio0Tagged 2024, cancer drugs, drug expansions, Drug Industry, Health care facility, Neoplasms, Novartis, Sales - occupational activity

Novartis, 2024 sales outlook, cancer drugs, drug expansions, pharmaceutical industry, healthcare, oncology.

Roche’s Strategic Shift Affects 20% of New Molecules, as Cancer Candidates are Reassessed

1 year ago talkbio0Tagged cancer candidates, Drug Development, Drug Industry, Molecule, oncology research, Roche (company), strategic shift

Roche, pipeline, rethink, new molecules, cancer candidates, discard pile, strategic shift, pharmaceutical industry, drug development, oncology research

Eli Lilly Expands Manufacturing Capacity with Nexus Plant Acquisition Amid Ongoing Mounjaro and Zepbound Supply Challenges

1 year ago talkbio0Tagged Acquisition (action), Capacity, Drug Industry, Drug shortages, Eli, Eli Lilly, Manufacture, Mounjaro, Nexus manufacturing, Plants, Wisconsin, Zepbound

Eli Lilly, Nexus manufacturing plant, Wisconsin, Mounjaro, Zepbound, drug shortages, manufacturing capacity, pharmaceutical industry, acquisition

Shimadzu Corporation Expands US Presence with Three New R&D Centers for Pharmaceutical Growth

1 year ago talkbio0Tagged business growth, Central, Corporation, Drug Industry, expansion, innovation, Shimadzu, Technology, U.S.

Shimadzu Corporation, R&D centers, US expansion, pharmaceutical industry, business growth, innovation, technology.

Novartis Appoints Ex-Bristol Myers CEO Giovanni Caforio as Chair: Potential for Future M&A Deals?

1 year ago talkbio0Tagged Acquisitions, Chairs, Corporate, Drug Industry, Giovanni Caforio, Leadership Change, M&A, mergers, Myers, Novartis

Novartis, Bristol Myers, Giovanni Caforio, Chair, Mergers and Acquisitions (M&A), Pharmaceutical Industry, Corporate Strategy, Leadership Change.

Sanofi’s Strategic Acquisition of Principia Bears Fruit with Rilzabrutinib’s Phase III Success

1 year ago talkbio0Tagged Acquisition (action), Biotechnology, Clinical Trials, Drug Development, Drug Industry, Investments, Phase III, Principia, Rilzabrutinib, sanofi, strategic, Success

Sanofi, Principia, acquisition, Rilzabrutinib, Phase III, clinical trial, success, strategic investment, pharmaceutical industry, biotechnology, drug development.

AbbVie Emerges as Leading Immunology Company in Doctor Rankings, Surpassing Pfizer and Johnson & Johnson

1 year ago talkbio0Tagged AbbVie, Drug Industry, Immunology, Johnson & Johnson, Market, Performance, Pfizer, Physicians, portfolio, product, reputation

AbbVie, Pfizer, Johnson & Johnson, doctor ranking, immunology companies, pharmaceutical industry, market performance, reputation, product portfolio.